Results 151 to 160 of about 3,398 (179)
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial [PDF]
Lancet, The, 2020 Background Intravenous ferric carboxymaltose has been shown to improve symptoms and quality of life in patients with chronic heart failure and iron deficiency.
Piotr Ponikowski +2 more
exaly +5 more sources
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose [PDF]
Journal of Perinatal Medicine, 2012 Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose.
Olivier Irion +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: